Medmidas Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 7 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -22.56%
- Profit Growth -86.40%
- Ebitda -85.31%
- Net Worth 1.91%
- Total Assets -5.00%
About Medmidas Healthcare
Medmidas Healthcare Private Limited (MHPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2012 and has a history of 13 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandrakant Agarwal and Gautam Agarwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100DL2012PTC231691
- Company No.
231691
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Medmidas Healthcare Private Limited offer?
Medmidas Healthcare Private Limited offers a wide range of products and services, including Anti Inflammatory Drugs, Deflazacort, Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Who are the key members and board of directors at Medmidas Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Agarwal  | Director | 17-Feb-2012 | Current |
| Chandrakant Agarwal | Director | 17-Feb-2012 | Current |
Financial Performance of Medmidas Healthcare.
Medmidas Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 22.56% decrease. The company also saw a substantial fall in profitability, with a 86.4% decrease in profit. The company's net worth moved up by a moderate rise of 1.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medmidas Healthcare?
In 2020, Medmidas Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trillenium Enerflow LimitedChandrakant Agarwal is a mutual person
- Jeekay Medical Private Limited
Gautam Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medmidas Healthcare?
Unlock and access historical data on people associated with Medmidas Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medmidas Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medmidas Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.